Professor Walker’s prolific research over 20 years has concerned the role of glucocorticoids in metabolic syndrome and cardiovascular disease. He published the original description of 11β-HSD1’s role in amplifying glucocorticoid action, identifying this enzyme as a prime therapeutic target. He has extensive experience collaborating with and advising pharmaceutical research and development.
In 2017, Brian was appointed as Pro Vice Chancellor for Research Strategy & Resources at Newcastle University, UK. He continues his research on glucocorticoids with colleagues at University of Edinburgh.